Cargando…

The use and efficacy of continuous glucose monitoring in type 1 diabetes treated with insulin pump therapy: a randomised controlled trial

AIMS/HYPOTHESIS: The aim of this multicentre, randomised, controlled crossover study was to determine the efficacy of adding continuous glucose monitoring (CGM) to insulin pump therapy (CSII) in type 1 diabetes. METHODS: Children and adults (n = 153) on CSII with HbA(1c) 7.5–9.5% (58.5–80.3 mmol/mol...

Descripción completa

Detalles Bibliográficos
Autores principales:	Battelino, T., Conget, I., Olsen, B., Schütz-Fuhrmann, I., Hommel, E., Hoogma, R., Schierloh, U., Sulli, N., Bolinder, J.
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Springer-Verlag 2012
Materias:	Article
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3483098/ https://www.ncbi.nlm.nih.gov/pubmed/22965294 http://dx.doi.org/10.1007/s00125-012-2708-9

Ejemplares similares

Impact of continuous glucose monitoring on quality of life, treatment satisfaction, and use of medical care resources: analyses from the SWITCH study
por: Hommel, E., et al.
Publicado: (2014)

Real-Life Management and Effectiveness of Insulin Pump with or Without Continuous Glucose Monitoring in Adults with Type 1 Diabetes
por: Viñals, Clara, et al.
Publicado: (2019)

Effect of Continuous Glucose Monitoring on Hypoglycemia in Type 1 Diabetes
por: Battelino, Tadej, et al.
Publicado: (2011)

Hypoglycemia Prevention and User Acceptance of an Insulin Pump System with Predictive Low Glucose Management
por: Choudhary, Pratik, et al.
Publicado: (2016)

Diabetes Technology Update: Use of Insulin Pumps and Continuous Glucose Monitoring in the Hospital
por: Umpierrez, Guillermo E., et al.
Publicado: (2018)

Managing Patients with Insulin Pumps and Continuous Glucose Monitors in the Hospital: to Wear or Not to Wear
por: Yeh, Tiffany, et al.
Publicado: (2021)

Integrated insulin pump therapy with continuous glucose monitoring for improved adherence: technology update
por: Tumminia, Andrea, et al.
Publicado: (2015)

Practical aspects of diabetes technology use: Continuous glucose monitors, insulin pumps, and automated insulin delivery systems
por: Marks, Brynn E., et al.
Publicado: (2021)

Advanced Technology in the Management of Diabetes: Which Comes First—Continuous Glucose Monitor or Insulin Pump?
por: Martin, Christopher T., et al.
Publicado: (2019)

Combining continuous glucose monitoring and insulin pumps to automatically tune the basal insulin infusion in diabetes therapy: a review
por: Vettoretti, Martina, et al.
Publicado: (2019)

Impact of real-time continuous glucose monitoring on glucose variability in critically ill patients
por: Brunner, R, et al.
Publicado: (2010)

Insulin edema after initiation of hybrid closed-loop insulin pump therapy with continuous glucose monitoring: a case report
por: Vasigh, Mostafa, et al.
Publicado: (2022)

Continuous Glucose Monitor, Insulin Pump, and Automated Insulin Delivery Therapies for Type 1 Diabetes: An Update on Potential for Cardiovascular Benefits
por: Pauley, Meghan E., et al.
Publicado: (2022)

Routine use of continuous glucose monitoring in 10 501 people with diabetes mellitus
por: Battelino, T., et al.
Publicado: (2015)

Steroid-Refractory Insulin Autoimmune Syndrome Treated With Rituximab and Continuous Glucose Monitoring
por: Batra, Chandar M, et al.
Publicado: (2021)

Intermittent Scanning Glucose Monitoring or Predicted Low Suspend Pump Treatment: Does It Impact Time in Glucose Target and Treatment Preference? The QUEST Randomized Crossover Study
por: Schierloh, Ulrike, et al.
Publicado: (2022)

Clinical Practice Recommendations on the Routine Use of Eversense, the First Long-Term Implantable Continuous Glucose Monitoring System
por: Deiss, Dorothee, et al.
Publicado: (2019)

Prediction of Nocturnal Hypoglycemia in Adults with Type 1 Diabetes under Multiple Daily Injections Using Continuous Glucose Monitoring and Physical Activity Monitor
por: Bertachi, Arthur, et al.
Publicado: (2020)

Effectiveness and Safety of Insulin Glargine 300 U/ml in Comparison with Insulin Degludec 100 U/ml Evaluated with Continuous Glucose Monitoring in Adults with Type 1 Diabetes and Suboptimal Glycemic Control in Routine Clinical Practice: The OneCARE Study
por: Conget, Ignacio, et al.
Publicado: (2021)

MON-002 Perspective of Graduating Endocrinology, Diabetes, and Metabolism Fellows on the Benefits of Wearing a Continuous Glucose Monitor and Insulin Pump for Their Education
por: Delgado, Juan, et al.
Publicado: (2019)

Continuous Glucose Monitoring Sensor Glucose Levels and Insulin Pump Infusion Set Wear-Time During Treatment with Fast-Acting Insulin Aspart: A Post Hoc Analysis of Onset 5
por: Gorst-Rasmussen, Anders, et al.
Publicado: (2022)

Accuracy of Continuous Glucose Monitoring before, during, and after Aerobic and Anaerobic Exercise in Patients with Type 1 Diabetes Mellitus
por: Biagi, Lyvia, et al.
Publicado: (2018)

An updated algorithm for an effective choice of continuous glucose monitoring for people with insulin-treated diabetes
por: Maiorino, Maria Ida, et al.
Publicado: (2023)

Use of continuous glucose monitoring in insulin-treated older adults with type 2 diabetes
por: Leite, Silmara A O, et al.
Publicado: (2023)

A Randomized Clinical Trial of the Effect of Continuous Glucose Monitoring on Nocturnal Hypoglycemia, Daytime Hypoglycemia, Glycemic Variability, and Hypoglycemia Confidence in Persons with Type 1 Diabetes Treated with Multiple Daily Insulin Injections (GOLD-3)
por: Ólafsdóttir, Arndís F., et al.
Publicado: (2018)

The majority of people with type 1 diabetes and multiple daily insulin injections benefit from using continuous glucose monitoring: An analysis based on the GOLD randomized trial (GOLD‐5)
por: Ólafsdóttir, Arndís F., et al.
Publicado: (2020)

Coronavirus lockdown effect on type 1 diabetes management οn children wearing insulin pump equipped with continuous glucose monitoring system
por: Christoforidis, Athanasios, et al.
Publicado: (2020)

An Overview of Insulin Pumps and Glucose Sensors for the Generalist
por: McAdams, Brooke H., et al.
Publicado: (2016)

Real-time continuous glucose monitoring versus self-monitoring of blood glucose in adults with insulin-treated type 2 diabetes: a protocol for a randomised controlled single-centre trial
por: Lind, Nanna, et al.
Publicado: (2021)

The Effect of Discontinuing Continuous Glucose Monitoring in Adults With Type 2 Diabetes Treated With Basal Insulin
por: Aleppo, Grazia, et al.
Publicado: (2021)

Insulin pump therapy with and without continuous glucose monitoring in pregnant women with type 1 diabetes: a prospective observational Orchestra Foundation study in Poland
por: Cypryk, Katarzyna, et al.
Publicado: (2023)

International Consensus on Use of Continuous Glucose Monitoring
por: Danne, Thomas, et al.
Publicado: (2017)

Continuous glucose monitoring
por: Pandit, Kaushik
Publicado: (2012)

Sustained efficacy of insulin pump therapy compared with multiple daily injections in type 2 diabetes: 12‐month data from the OpT2mise randomized trial
por: Aronson, R., et al.
Publicado: (2016)

The impact of strict COVID-19 lockdown in Spain on glycemic profiles in patients with type 1 Diabetes prone to hypoglycemia using standalone continuous glucose monitoring
por: Mesa, Alex, et al.
Publicado: (2020)

Intensive insulin therapy in the intensive care unit: assessment by continuous glucose monitoring
por: De Block, C, et al.
Publicado: (2005)

Continuous Glucose Monitoring in Patients With Type 1 Diabetes Using Insulin Injections
por: Foster, Nicole C., et al.
Publicado: (2016)

Feasibility of automated insulin delivery guided by continuous glucose monitoring in preterm infants
por: Beardsall, Kathryn, et al.
Publicado: (2020)

Continuous subcutaneous insulin infusion and flash glucose monitoring in diabetic hemiballism-hemichorea
por: Qiang, Wei, et al.
Publicado: (2020)

Effectiveness of continuous glucose monitoring in pregnant women with diabetes: randomised clinical trial
por: Murphy, Helen R, et al.
Publicado: (2008)

Cannot write session to /tmp/vufind_sessions/sess_qt01dvchd0ce8eb6l5sk6u4ag6